Sorry, you need to enable JavaScript to visit this website.

This website is intended for healthcare professionals in KSA and UAE only.

The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

This website is intended for healthcare professionals in KSA and UAE only.
 The content provided is developed in accordance with local regulations and may not be applicable or compliant in other regions.

Icon Search
hamburguer menu

Search results

hamburguer menu

IgAN explained


Download IgAN information
Download

MECHANISM OF DISEASE

IgA nephropathy (IgAN) is characterized by glomerular deposition of immune complexes containing galactose-deficient IgA1 that lead to kidney damage1–5

There are 4 processes or ‘Hits’ involved in the pathogenesis of IgAN:6,7

Mechanism of disease

Image adapted from Suzuki H, et al. 20116

This formation of pathogenic IgA1-containing immune complexes triggers:1–3

Formation of pathogenic IgA1-containing

Different stages of pathology in IgA nephropathy7

pathology in IgA
  1. IgAN at an early stage, with minimal mesangial expansion and preserved glomerular capillary tufts (that is, a network of capillaries) architecture. Periodic acid-silver methanamine, haematoxylin and eosin counterstain, 360× magnification
pathology in IgA
  1. Small segmental sclerosis (25%) with capillary collapse (thin arrow) and capsular adhesion (thick arrow). Periodic acid-silver methanamine, haematoxylin and eosin counterstain, 360× magnification
pathology in IgA
  1. Significant segmental sclerosis (50% of the glomerular area) with capillary collapse and consolidation (*), hyalinosis (thin arrow) and capsular adhesion (thick arrow). Periodic acid-silver methanamine, haematoxylin and eosin counterstain, 360× magnification
pathology in IgA
  1. Advanced glomerulosclerosis or glomerular obsolescence (>75%), with associated tubular atrophy and interstitial fibrosis. Periodic acid-silver methanamine, haematoxylin and eosin counterstain, 180× magnification

Image adapted from Lai KN, et al. 20167

Background

MoD video for IgAN

View video
Icon view video

References & footnotes

Arrow white

Abbreviations

GFR, glomerular filtration rate; IgA, Immunoglobulin A; IgA1, Immunoglobulin A-1; IgAN, IgA nephropathy.

References

  1. Wyatt R, Julian B. IgA Nephropathy. N Engl J Med. 2013; 368:2402–14.
  2. Barratt J, Feehally J. IgA Nephropathy. J Am Soc Nephrol. 2005; 16:2088–97.
  3. Boyd JK, et al. An update on the pathogenesis and treatment of IgA nephropathy. Kidney Int. 2012; 81:833–43.
  4. Aucella F, et al. Proteinuria in the prognosis of IgA nephropathy. Minerva Urol Nefrol. 2009; 61:235–48.
  5. Remuzzi G, Bertani T. Pathophysiology of Progressive Nephropathies. N Engl J Med. 1998; 339:1448–56.
  6. Suzuki H, et al. The Pathophysiology of IgA Nephropathy.  J Am Soc Nephrol. 2011; 22:1975–1803.
  7. Lai KN, et al. IgA nephropathy. Nat Rev Dis Primers. 2016; 2:16001.

HQ-SPT-2500012 | Date of preparation: February 2025